David Hawkings: New bill aims to loosen FDA’s drug testing rules
August 15, 20179:57 am
< a min read
The Food and Drug Administration — and in particular its ability to collect crucial fees — is at stake in a new legislative proposal. Sen. Ron Johnson (R-Wis.) wants to give drug companies more leeway to let people try drugs experimentally. For more on this and other congressional doings, Federal Drive with Tom Temin turns to Roll Call Senior Editor David Hawkings.
David Hawkings: What August looks like on Capitol Hill